In a hospital in Wuwei, northwest China's Gansu Province, a medical facility consisting of large pieces of steel and complex coils occupies a building of 30 meters high. The high-speed carbon ions produced by it are channeled into the treatment room to kill the tumor cells of cancer patients.
China aims to raise the overall five-year survival rate for cancers to over 46.6 percent by 2030 by rolling out comprehensive measures including promoting healthy lifestyles, expanding screening and accelerating the development of new technologies.
The death of a Chinese singer who shared his excruciating battle with oral cancer caused by his habit of chewing betel nuts has rekindled discussions about tightening controls on sales of the addictive snack that has long been in the shadow of its links to cancer.
Developed by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., a subsidiary of 3SBio, Inetetamab was approved for clinical use by the National Medical Products Administration on June 19.
China has approved its first domestically made vaccine against the cancer-causing human papillomavirus for use by females aged 9 to 45, providing an alternative to foreign drugmakers' products, according to the National Medical Products Administration.